The carboxylic ionophore, monensin, blocks the migration of glycoprotein-containing vesicles from the Golgi region to the plasma membrane in fibroblasts resulting in an accumulation of secretory products in the Golgi cisternae. Treatment of cultured I-cell fibroblasts with monensin (0.5,UM) decreased the abnormal excretion of f-hexosaminidase to 40% of untreated cultures within 15 min. A corresponding intracellular accumulation of the enzyme to >200% of untreated cultures by 24 h was also observed.
I-cell disease (mucolipidosis II) is an autosomal recessive, neurodegenerative disorder, characterized biochemically by an abnormal accumulation of most lysosomal hydrolases in the culture fluid of skin fibroblasts derived from patients (Wiesmann et al., 1971) . Unlike hydrolases excreted by normal fibroblasts, I-cell-excreted lysosomal enzymes are not pinocytosed by non-I-cell fibroblasts (Hickman & Neufeld, 1972) . This observation led to the hypothesis that in normal fibroblasts, the final packaging oflysosomal enzymes required initially a secretion of the enzymes and then pinocytosis via cell receptors that interacted with a carbohydrate recognition marker on the enzymes (Hickman et al., 1974) . It was suggested that in I-cell fibroblasts this marker was absent from the excreted enzymes thus resulting in extracellular accumulation of the enzymes (Hickman & Neufeld, 1972) . It was later found that the recognition marker on fibroblast-derived hydrolases is mannose 6-phosphate (Kaplan et al., 1977; Sando & Neufeld, 1977; Ullrich et al., 1978) .
We and others have shown, however, that in normal cultures the excretion-re-uptake route only involves 12-15% of the total enzyme when using the lysosomal hydrolase, f-N-acetyl-D-glucosaminidase (EC 3.2.1.30; , as the prototype Vladutiu & Rattazzi, 1979a) . We have further shown that the excessive extracellular accumulation of hydrolases in I-cell cultures cannot be accounted for by an impairment of the re-uptake mechanism (Vladutiu & Rattazzi, 1979a) . These findings are consistent with our previous proposal that the accumulation of lysosomal enzymes in I-cell culture fluids results from preferential exocytosis (Vladutiu & Rattazzi, 1975 ). The precise biochemical defect in I-cell disease and its site of action with respect to intracellular hydrolase processing has not been determined.
Monensin is a low-molecular-weight (mol.wt. 680) carboxylic ionophore (Pressman, 1976 ) with a selective affinity for Na+ and K+, which imposes a high Na+ and low K+ concentration in mouse plasma cells and in human fibroblasts and impairs the migration of Golgi-derived vesicles to the cell surface, thus inhibiting the excretion of their contents (Tartakoff & Vassalli, 1977 Uchida et al., 1979 (20, ug/ml; Grand Island Biologicals, Grand Island, NY, U.S.A.) . The collection of fibroblast secretions, the preparations of cell extracts and enzyme assay methods have been described (Vladutiu & Rattazzi, 1975) . The fluorogenic substrate, 4-methylumbelliferyl-N-acetylglucosamine (Pierce Chemical Co., Rockford, IL, U.S.A.) was used for the assay of fJ-hexosaminidase and for the detection of electrophoretic patterns (Vladutiu & Rattazzi, 1975) . One enzyme unit was defined as the activity that liberated 1 nmol of 4-methylumbelliferone/h at 370 C. Lactate dehydrogenase activity in cell-culture fluids was determined by the method of Wroblewski & LaDue (1955) with a commercial kit (340-UV; Sigma Chemical Co.).
Electrophoresis
Electrophoresis of,B-hexosaminidase from normal and I-cell extracts and culture fluids was carried out on cellulose acetate gel (Cellogel; Kalex, Manhasset, NY, U.S.A.) in 36mM-sodium barbital/citric acid buffer, pH 6, as previously described (Rattazzi etal., 1975) .
Protein
Protein concentrations were measured by using the Coomassie Blue dye-binding method of Bradford (1976) .
Monensin effect on f3-hexosaminidase distribution Monolayer cultures of normal, I-cell and cysticfibrosis fibroblasts were incubated with increasing concentrations of monensin (0.5-4.0,UM) in serumfree medium containing 0.25% human serum albumin at 370C for 24h. The intra-and extra-cellular fJ-hexosaminidase activity was assayed in each culture at the end of the incubation period. The cytotoxicity of monensin was assessed by quantifying the release of lactate dehydrogenase activity from fibroblasts into the culture fluid.
A time-exposure study of the effect of monensin (0.5juM) was carried out on normal, I-cell homozygote and I-cell heterozygote fibroblast cultures.
The f,-hexosaminidase and lactate dehydrogenase activities were measured in the culture fluids of monolayers treated with monensin for 15 min to 72 h. The intracellular ,J-hexosaminidase activity was assayed at intervals beginning at 1 h after treatment up to 72h.
The fraction of newly synthesized f,-hexosaminidase (units/pg of cell protein) in the intra-and extra-cellular pools was estimated in normal and I-cell cultures treated with 0.5#uM-monensin for 24 and 48 h. This estimation was based on the results of previous experiments with cycloheximide treatment of normal and I-cell cultures (Vladutiu & Rattazzi, 1979b) .
Mannose 6-phosphate-mediated uptake of fJ-hexos- aminidase We have previously shown that the incubation of normal fibroblast cultures with 2 mM-mannose 6-phosphate for 24h caused an inhibition of re-uptake of a small but significant portion (2% daily) of high-uptake fJ-hexosaminidase, which was excreted by the cells (Vladutiu & Rattazzi, 1979a) . The effect of monensin (0.5pM) on the specific re-uptake of f,-hexosaminidase in normal fibroblast cultures by altering the mannose 6-phosphate-recognition marker on the enzyme or the mannose 6-phosphate receptor on the cell membrane was assessed, and the specific effect of monensin on I-cell /J-hexosaminidase excretion was determined by incubating monolayers with 1 ml of serum-free medium containing 0.5,uM-monensin or 2mM-mannose 6-phosphate or 0.5,uM-monensin + 2mM-mannose 6-phosphate/dish at 370C for 24h. At the end of the incubation period, the respective cell monolayers and culture fluids were harvested and assayed for ,B-hexosaminidase activity.
The effect of monensin on the ability of Sandhoff fibroblasts to pinocytose high-uptake (Glaser et al., 1975) fJ-hexosaminidase was also determined.
Monolayers of Sandhoff fibroblasts were pretreated with 2ml of either 0.5,uM-monensin in serum-free medium or serum-free medium alone/dish at 370C for 24h. Those cultures pretreated with monensin were then incubated with serum-free medium containing high-uptake fi-hexosaminidase + 0.5gum-monensin at 370C for 5h. The untreated cultures were incubated with high-uptake enzyme alone. The amount of enzyme taken up by the cells was quantified by determining the concentration of f-hexosaminidase per ug of cell protein (corrected for endogenous enzyme activity). The high-uptake enzyme preparation used for this experiment was collected from the culture fluid of normal fibroblast cultures treated with 25 or 50,uM-chloroquine + 2mM-mannose 6-phosphate at 370C for 18h (Gonzalez-Noriega et al., 1980) . The fluids from several cultures were pooled, concentrated by ultrafiltration at 40C (membrane XM 100; Amicon Corp., Lexington, MA, U.S.A.) and dialysed overnight at 40C against 1000vol. of serum-free medium + Hanks' balanced salt (HBS) solution
The uptake of excreted f1-hexosaminidase obtained from normal fibroblasts exposed to 0.5 pMmonensin was also determined to see if monensin influenced the intracellular processing of 6-hexosaminidase, which was destined for excretion, resulting in an abnormal enzyme product. Monolayers of normal fibroblasts were incubated with 0.5,UMmonensin in serum-free medium at 370C for 24h. The culture fluids were harvested, concentrated and dialysed. Monolayers of Sandhoff fibroblasts were preincubated with serum-free medium at 370C for 24 h and then exposed to the dialysed ,J-hexosaminidase derived from monensin-treated normal cells for a 5h uptake period. After uptake, the cells were harvested, extracted and assayed forf,-hexosaminidase activity.
A possible direct effect of monensin on highuptake 13-hexosaminidase derived from normal fibroblast culture fluids was also assessed, to determine if pretreatment of the enzyme with monensin altered its specificity for receptor-mediated uptake. A preparation of high-uptake enzyme was collected from normal fibroblasts in the presence of chloroquine + mannose 6-phosphate, then concentrated and dialysed as described above. Monensin was added to the enzyme preparation to a final concentration of 0.5,M. As a control, a second portion of the enzyme was mixed with serum-free medium alone. Both preparations were incubated at 370C for 24 h then dialysed against serum-free medium + HBS Vol. 192 solution overnight. The treated and untreated enzyme preparations were applied to Sandhoff cell monolayers for a 5h uptake period at 370C. The cells were harvested, extracted and assayed for f-hexosaminidase activity.
Concanavalin A precipitation
The binding affinity of concanavalin A for mannose residues was used to assess whether any of the fJ-hexosaminidase isoenzyme excreted from monensin-treated normal and I-cell cultures had any major alterations in their mannose composition. The procedure will be described in detail elsewhere (G. D. Vladutiu & M. C. Rattazzi, unpublished work) . Briefly, culture fluids from monensin-treated normal and I-cell cultures and from corresponding untreated cultures were adjusted to af,-hexosaminidase concentration of 500units/ml and lO,ul of each was submitted to electrophoresis on cellulose acetate gel. After electrophoresis, each lane was overlaid with 40,1 of a solution containing 160,ug of concanavalin A/ml. The gel was then incubated in a moisture chamber at 370C for 2h, washed overnight in saline to remove any enzyme not precipitated by concanavalin A and finally stained for J-hexosaminidase activity with the fluorogenic substrate.
Results

Monensin effect on f-hexosaminidase distribution
The effects of increasing concentrations of monensin on the excretion of f-hexosaminidase from normal, I-cell and cystic-fibrosis fibroblasts are presented in Fig. 1 . In the I-cell cultures, a progressive inhibition of excretion occurred until excretion was maximally decreased to 40% of the corresponding untreated cultures with 4,uM-monensin. In normal and cystic-fibrosis cultures, excretion was increased to a maximum of 70 and 40% over untreated cultures respectively with only 0.5,UMmonensin (Fig. 1) . However, normal and cysticfibrosis cells usually only excrete .15% of their total cellular fJ-hexosaminidase in 24h (Vladutiu & Rattazzi, 1979a) ; hence, monensin only effected a modest net increase in excretion of 10%. I-cell fibroblasts excrete 85-90% of their total fi-hexosaminidase in 24h (Vladutiu & Rattazzi, 1979a) ; hence, a 60% decrease in excretion affected 51-54% of the total enzyme. An enhanced release of lactate dehydrogenase, suggesting a cytotoxic effect of monensin, was apparent only in the cystic-fibrosis cultures, reach- ing a maximum of 3.8-fold over controls with 4#uM-monensin.
The time-dependent effect of 0.5puM-monensn on the excretion of ,-hexosaminidase during the first hour of incubation is presented in Fig. 2 In previous experiments, we determined that in cycloheximide-treated I-cell cultures, 40% of the intracellular and 91% of the excreted enzyme was newly synthesized. In similarly treated normal cell cultures, 16% of the intracellular and 5% of the excreted fJ-hexosaminidase was newly synthesiiid (Vladutiu & Rattazzi, 1979b) . The distribution of newly synthesized ,J-hexosaminidase in normal and I-cell fibroblast cultures treated with monensin for 24 and 48 h is presented in Fig. 3 . The concentrations of f-hexosaminidase in both the normal and I-cell culture fluids and in the corresponding extracts begin to converge by 24h. That is, as fJ-hexosaminidase excretion is substantially decreased in I-cell cultures, it is increased in normal cultures; an intracellular accumulation of the enzyme occurs in both normal and I-cell fibroblasts. This process, however, is more pronounced and more rapid in I-cell than in normal cells during the first 24 h exposure to monensin.
Mannose 6-phosphate-mediated uptake of fi-hexosaminidase Although monensin slightly enhanced the excretion of fI-hexosaminidase in normal fibroblast cultures (Figs. 1-3 ), this excreted enzyme was not a high-uptake form. This was demonstrated when mannose 6-phosphate failed to enhance the extracellular accumulation of the enzyme in monensin-treated normal cultures above the expected enhanced accumulation (2% of total daily value) in cultures treated only with mannose 6-phosphate (Vladutiu & Rattazzi, 1979a) (Fig. 4) , and by the fact that the enzyme derived from monensin-treated normal fibroblasts was not endocytosed by Sandhoff-disease fibroblasts during 5 h uptake experiments (Table 2) . However, monensin also had an effect on the mannose 6-phosphate cell receptors and/or internalization of the enzyme as evidenced by a 65% decrease in the ability of monensin-treated Sandhoff fibroblasts to pinocytose high-uptake ,6-hexosaminidase (Table 2) conversion of the excreted enzyme into a highuptake form resulting in specific re-uptake of the enzyme, because the addition of mannose 6-phosphate to monensin-treated I-cell cultures did not increase the extracellular accumulation of 16-hexosaminidase (Fig. 4) .
Incubation in vitro of high-uptake f,-hexosaminidase with 0.5juM-monensin for 5h followed by dialysis to remove the monensin, did not affect the subsequent uptake of the enzyme by Sandhoff fibroblasts. Hence, there appeared to be no direct effect of monensin on the enzyme itself in vitro. An effect on the intracellular processing of fl-hexosaminidase, however, resulting in an alteration of the recognition marker on the enzyme was apparent in the production of a 'no-uptake' (Vladutiu & Rattazzi, 1979a ) excreted form from monensintreated normal cells (Fig. 4 and Table 2 ). (1) and (3) All the fl-hexosaminidase isoenzymes in the culture fluids of monensin-treated normal and I-cell fibroblasts were precipitated in cellulose acetate gel after electrophoresis and overlay with concanavalin A, indicating the presence of mannose residues in the carbohydrate composition of the isoenzymes.
Discussion
In I-cell fibroblast cultures, monensin caused a rapid decrease of extracellular J-hexosaminidase with a corresponding intracellular accumulation. In view of the intracellular build-up of fl-hexosaminidase in I-cell fibroblasts, it is likely that monensin inhibited the excretion of newly synthesized enzyme resulting in its accumulation presumably in the Golgi region. This finding differs from our previous observations of decreased excretion of f-hexosaminidase induced by tunicamycin, cycloheximide (Vladutiu & Rattazzi, 1979b) or 250C culture temperature (Vladutiu, 1979) , with no intracellular accumulation. These treatments appeared to have inhibited mainly protein synthesis.
The fact that excretion from I-cell fibroblasts was not totally blocked, as evidenced by the excretion of a small amount of the I-cell intracellular-type isoenzymes and that similar isoenzymes were also excreted by monensin-treated normal cells, suggests that two phenomena resulted from monensin treatment: (1) prevention of excretion from a late-or post-Golgi region (mainly evident in I-cell fibroblasts); (2) appearance of a minimal excretion from a secondary pathway in the cells, perhaps from pre-Golgi vesicles (transitional elements from endoplasmic reticulum) in both normal and I-cell fibroblasts. Evidence for pre-Golgi-region vesicles has been established in pancreatic exocrine cells (Jamieson & Palade, 1977) and in Chinese hamster ovary cells (Rothman & Fine, 1980) ; a direct secretion route via smooth-endoplasmic-reticulum vesicles has been shown in rat liver cells (Morre et al., 1974) . It is possible that excretion from this secondary route occurs regularly in normal and I-cell fibroblasts, but is not observable when the more prominent post-Golgi route is functioning, or that it is operative only when there is a back-up of secretory products in the Golgi region.
The I-cell intracellular-type isoenzymes of fBhexosaminidase excreted in both monensin-treated normal and I-cell cultures did not appear to possess the mannose 6-phosphate-recognition marker necessary for uptake by normal or Sandhoff fibroblasts. This supports our contention of pre-Golgi excretion as the enzyme may have been excreted before being fully processed, before either complete glycosylation (Rothman & Fine, 1980) and/or phosphorylation (Hasilik & Neufeld, 1980 ). An alteration in glycosylation, either in the intracellular assembly (Vladutiu & Rattazzi, 1975) or in the degradation (Vladutiu, 1978) of carbohydrate chain(s) constituting the mannose 6-phosphate-recognition marker complex, could result in excretion of the I-cell hydrolases as they could no longer be retained in subcellular vesicles on fusion with the plasma membrane (Lloyd, 1977) . However, retention of internalized high-uptake /l-
glucuronidase in endocytic vacuoles does not require the mannose 6-phosphate-recognition marker (Glaser et al., 1975) . It may be that different subcellular vesicles comprising the Golgi-lysosomalvacuolar system in fibroblasts have different receptor specificities for lysosomal enzymes. In I-cell disease, lysosomal enzymes may enter the excretory vesicles of the system before being fully processed or after being improperly processed with respect to glycosylation (Vladutiu & Rattazzi, 1978) . Hasilik & Neufeld (1980) have suggested that in normal fibroblasts, the phosphorylation of fI-hexosaminidase precursors normally occurs at a nonlysosomal site and does not occur at all in I-cell fibroblasts. A defect in either the phosphorylation of hydrolases (Ullrich et al., 1978; Bach et al., 1979) or the specific glycosyl residue to which the phosphate is attached (Bach et al., 1979) has been postulated as the primary defect in I-cell disease. This, however, does not imply re-uptake as a problem in I-cell disease (Vladutiu & Rattazzi, 1979a) , but may involve the conversion of a non-secretory product to a secretory one (Sly & Stahl, 1978) . The unaltered electrophoretic pattern of the intracellular fl-hexosaminidase in monensin-treated normal cultures is explainable by our contention that only the small fraction of newly synthesized enzyme inside normal cells was affected by monensin (Vladutiu & Rattazzi, 1979b) . The bulk of preexisting enzyme, already packaged in lysosomes, could not have been affected. I-cell fibroblasts, in contrast, doubled their intracellular enzyme concentration in the presence of monensin (Table 1 ). An electrophoretic change in this accumulated enzyme was not apparent because the effect of monensin resulted in an enzyme form that was electrophoretically indistinguishable from the usual I-cell internal enzyme. The inability of monensin-treated Sandhoff fibroblasts to pinocytose high-uptake JJ-hexosaminidase may represent an inhibition of the migration of receptor proteins from the Golgi cisternae to the plasma membrane during membrane biogenesis (Farquhar, 1978) . Our findings with monensin treatment were: (1) that the newly synthesized ,-hexosaminidase excreted by both normal and I-cell fibroblasts converged toward the same value by 48h; (2) that the intracellular build-up of the enzyme in I-cell fibroblasts also approached normal values in 48h; and (3) that electrophoretically identical isoenzymic forms of f,-hexosaminidase were excreted by both normal and I-cell cultures, which all suggest that the subcellular site of the I-cell defect is after the site of the monensin effect i.e. late in the Golgi region or at a post-Golgi location.
Since the intracellular accumulation of fl-hexosaminidase in monensin-treated I-cell fibroblasts is presumably confined to the Golgi region and does not involve lysosomes, monensin is not a 'treatment' for I-cell disease at the lysosomal level in fibroblasts. Our findings, however, contribute to localizing the site of the I-cell defect and to understanding the steps involved in the subcellular processing of lysosomal enzymes.
